IMVT
Immunovant, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Expected move
Inputs8Q avg ±9.2%·×0.42·cheap
straddle ±14.4%
spot 29.17exp Nov 20ATM strike 29ATM straddle 4.95IV 89%
+1.17%
vs ±9.0% implied · ×0.13
shaded = implied · ▲▼ = realized
Linked news
No thesis.
Immunovant, Inc.
29.14
−0.50 · −1.68%
post 29.57 +1.47%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $623.7M | 14.39% | −4.49% | |
| 2 | Deep Track CapitalDeep Track Capital | $359.9M | 8.31% | −18.96% | |
| 3 | BlackRockBlackRockindex-like | $276.7M | 6.38% | +9.22% | |
| 4 | Farallon Capital ManagementFarallon | $223.7M | 5.16% | +275.49% | |
| 5 | Baker Bros. AdvisorsBaker Bros. | $209.4M | 4.83% | −0.42% | |
| 6 | State StreetState Streetindex-like | $177.9M | 4.11% | +1.74% | |
| 7 | Morgan StanleyMorgan Stanley | $174.7M | 4.03% | +16.97% | |
| 8 | TCG Crossover ManagementTCG Crossover | $171.8M | 3.96% | 0.00% | |
| 9 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $150.7M | 3.48% | +5.55% | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $140.2M | 3.24% | +0.51% | |
| 11 | Jennison AssociatesJennison | $127.5M | 2.94% | +3.55% | |
| 12 | RTW InvestmentsRTW | $122.4M | 2.83% | 0.00% | |
| 13 | Two Seas CapitalTwo Seas Capital | $121.3M | 2.80% | −1.67% | |
| 14 | Armistice CapitalArmistice Capital | $113.1M | 2.61% | −46.28% | |
| 15 | ADAR1 Capital ManagementADAR1 | $89.8M | 2.07% | −13.00% | |
| 16 | Geode Capital ManagementGeodeindex-like | $86.1M | 1.99% | +6.81% | |
| 17 | T. Rowe Price Investment ManagementT. Rowe Price | $85.6M | 1.98% | −38.49% | |
| 18 | Woodline PartnersWoodline Partners | $76.1M | 1.76% | 0.00% | |
| 19 | T. Rowe Price AssociatesT. Rowe Price | $70.5M | 1.63% | +438.63% | |
| 20 | Goldman Sachs GroupGoldman Sachs | $67.5M | 1.56% | −1.90% | |
| 21 | Alpine Partners VIAlpine Partners VI | $53.0M | 1.22% | −47.86% | |
| 22 | Susquehanna International GroupSusquehanna International | $52.7M | 1.22% | +12.36% | |
| 23 | Perceptive AdvisorsPerceptive | $52.3M | 1.21% | −15.02% | |
| 24 | D. E. ShawD. E. Shaw | $47.8M | 1.10% | new | |
| 25 | Bank of AmericaBank of America | $45.5M | 1.05% | +32.20% |
227 managers report $4.3B of Immunovant on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; FMR is largest at 14.39%.